[1]Hoogduijn MJ, Dor FJ. Mesenchymal stem cells: are we ready for clinical application in transplantation and tissue regeneration. Front Immunol. 2013;4:144.
[2]Wang TH, Lee YS, Hwang SM.Transcriptome analysis of common gene expression in human mesenchymal stem cells derived from four different origins.Methods Mol Biol. 2011; 698:405-417.
[3]Hsiao ST, Asgari A, Lokmic Z,et al. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue.Stem Cells Dev. 2012;21(12):2189-2203.
[4]Jin HJ, Bae YK, Kim M,et al. Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy.Int J Mol Sci. 2013;14(9):17986-18001.
[5]Aldahmash A, Zaher W, Al-Nbaheen M, et al. Human stromal (mesenchymal) stem cells: basic biology and current clinical use for tissue regeneration.Ann Saudi Med. 2012;32(1):68-77.
[6]Zou JP, Huang S, Peng Y,et al. Mesenchymal stem cells/ multipotent mesenchymal stromal cells (MSCs): potential role in healing cutaneous chronic wounds.Int J Low Extrem Wounds. 2012;11(4):244-253.
[7]Dash SN, Dash NR, Guru B,et al. Towards reaching the target: clinical application of mesenchymal stem cells for diabetic foot ulcers.Rejuvenation Res. 2014;17(1):40-53.
[8]Pileggi A, Xu X, Tan J,et al. Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials.Curr Opin Organ Transplant. 2013;18(6): 672-681.
[9]Zaher W, Harkness L, Jafari A,et al. An update of human mesenchymal stem cell biology and their clinical uses.Arch Toxicol. 2014;88(5):1069-1082.
[10]Walenda G, Hemeda H, Schneider RK,et al. Human platelet lysate gel provides a novel three dimensional-matrix for enhanced culture expansion of mesenchymal stromal cells.Tissue Eng Part C Methods. 2012;18(12):924-934.
[11]Bieback K, Hecker A, Kocaömer A, et al. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.Stem Cells. 2009;27(9): 2331-2341.
[12]Felka T, Schäfer R, De Zwart P,et al. Animal serum-free expansion and differentiation of human mesenchymal stromal cells.Cytotherapy. 2010;12(2):143-153.
[13]Chieregato K, Castegnaro S, Madeo D,et al. Epidermal growth factor, basic fibroblast growth factor and platelet-derived growth factor-bb can substitute for fetal bovine serum and compete with human platelet-rich plasma in the ex vivo expansion of mesenchymal stromal cells derived from adipose tissue.Cytotherapy. 2011;13(8): 933-943.
[14]Poloni A, Maurizi G, Serrani F,et al. Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate.Cell Prolif. 2012;45(1):66-75.
[15]Murphy MB, Blashki D, Buchanan RM,et al. Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation.Biomaterials. 2012;33(21):5308-5316.
[16]Kishimoto S, Ishihara M, Mori Y,et al. Effective expansion of human adipose-derived stromal cells and bone marrow-derived mesenchymal stem cells cultured on a fragmin/protamine nanoparticles-coated substratum with human platelet-rich plasma.J Tissue Eng Regen Med. 2013; 7(12):955-964.
[17]Bertolo A, Mehr M, Janner-Jametti T,et al. An in vitro expansion score for tissue-engineering applications with human bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med. 2013. [Epub ahead of print]
[18]Honmou O, Houkin K, Matsunaga T, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.Brain. 2011;134(Pt 6): 1790-1807.
[19]Pérez-Simon JA, López-Villar O, Andreu EJ,et al. Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.Haematologica. 2011;96(7):1072-1076.
[20]Jung S, Panchalingam KM, Wuerth RD, et al. Large-scale production of human mesenchymal stem cells for clinical applications.Biotechnol Appl Biochem. 2012;59(2):106-120.
[21]Song HJ, Zhang P, Guo XJ,et al.The proteomic analysis of human neonatal umbilical cord serum by mass spectrometry.Acta Pharmacol Sin. 2009;30(11):1550-1558.
[22]Jung J, Moon N, Ahn JY,et al. Mesenchymal stromal cells expanded in human allogenic cord blood serum display higher self-renewal and enhanced osteogenic potential. Stem Cells Dev. 2009;18(4):559-571.
[23]Ng F, Boucher S, Koh S,et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages.Blood. 2008;112(2):295-307.
[24]李斯翰,段建民,李洪涛,等.改良富血小板血浆对骨髓间充质干细胞增殖与免疫原性的作用[J].中国组织工程研究,2013,17(49): 8505-8511.
[25]Fekete N, Gadelorge M, Fürst D,et al. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components.Cytotherapy. 2012;14(5):540-554.
[26]Busilacchi A, Gigante A, Mattioli-Belmonte M,et al. Chitosan stabilizes platelet growth factors and modulates stem cell differentiation toward tissue regeneration.Carbohydr Polym. 2013;98(1):665-676.
[27]Yokota J, Chosa N, Sawada S,et al. PDGF-induced PI3K-mediated signaling enhances the TGF-β-induced osteogenic differentiation of human mesenchymal stem cells in a TGF-β-activated MEK-dependent manner.Int J Mol Med. 2014;33(3):534-542.
[28]Jose S, Hughbanks ML, Binder BY,et al. Enhanced trophic factor secretion by mesenchymal stem/stromal cells with Glycine-Histidine-Lysine (GHK)-modified alginate hydrogels. Acta Biomater. 2014;10(5):1955-1964.
[29]Pallua N, Serin M, Wolter TP. Characterisation of angiogenetic growth factor production in adipose tissue-derived mesenchymal cells.J Plast Surg Hand Surg. 2014. [Epub ahead of print].
[30]Contaldo C, Myers TJ, Zucchini C, et al. Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cells.Growth Factors. 2014;32(1):41-52.
[31]Jonsdottir-Buch SM, Lieder R, Sigurjonsson OE. Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells.PLoS One. 2013;8(7):e68984.
[32]Santo VE, Duarte AR, Popa EG,et al. Enhancement of osteogenic differentiation of human adipose derived stem cells by the controlled release of platelet lysates from hybrid scaffolds produced by supercritical fluid foaming.J Control Release. 2012;162(1):19-27.
[33]Gottipamula S, Sharma A, Krishnamurthy S,et al. Human platelet lysate is an alternative to fetal bovine serum for large-scale expansion of bone marrow-derived mesenchymal stromal cells.Biotechnol Lett. 2012;34(7):1367-1374.
[34]Cholewa D, Stiehl T, Schellenberg A,et al. Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density.Cell Transplant. 2011; 20(9):1409-1422.
[35]Naaijkens BA, Niessen HW, Prins HJ,et al. Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications.Cell Tissue Res. 2012;348(1):119-130.
[36]董晶,聂李平,周宇,等.血小板裂解液快速扩增人羊膜来源间充质干细胞[J].微循环学杂志,2012,22(4): 13-16.
[37]Abdelrazik H, Spaggiari GM, Chiossone L,et al. Mesenchymal stem cells expanded in human platelet lysate display a decreased inhibitory capacity on T- and NK-cell proliferation and function.Eur J Immunol. 2011;41(11):3281-3290.
[38]van der Valk J, Brunner D, De Smet K,et al. Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods.Toxicol In Vitro. 2010; 24(4):1053-1063.
[39]Mimura S, Kimura N, Hirata M,et al. Growth factor-defined culture medium for human mesenchymal stem cells.Int J Dev Biol. 2011;55(2):181-187.
[40]Hudson JE, Mills RJ, Frith JE,et al. A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors.Stem Cells Dev. 2011;20(1):77-87.
[41]Dominici M, Le Blanc K, Mueller I,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317. |